Management of Hyperthermic
Intraperitoneal Chemotherapy (HIPEC)
after Cytoreductive Surgery (CRS)
19-21 M A R C H
2015
HAMBURG
EUROPEAN SCHOOL OF PERITONEAL
SURFACE ONCOLOGY
Management of Hyperthermic Intraperitoneal
Chemotherapy (HIPEC) after Cytoreductive
Surgery (CRS)
Course directors
Chair: Beate Rau, Charité Campus Mitte, Berlin, DE Co-Chair: Marcello Deraco, Fondazione IRCCS Istituto
Nazionale dei Tumori, Milano, IT
Experts in the field
Dario Baratti MD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, IT
Tom Cecil MD, Basingstoke and North Hampshire Hospital, Basingstoke, UK
Olivier Glehen MD, Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon, FR
Gabriel Glockzin MD, University of Regensburg, Regensburg, DE
Santiago González-Moreno MD, MD Anderson Cancer Center, Madrid, ES
Ludwig K. Groebler MD, European Surgical Institute (ESI), Hamburg, DE
Jens Hartmann DVM, AKH, Celle DE
Maik Kilian MD, Charité Campus Mitte, Berlin, DE
Christhardt Köhler MD, Charité Campus Mitte, Berlin, DE
Shigeki Kusamura MD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, IT
Massimo Milione MD, Institute of Pathology, Fondazione IRCCS Istituto Nationale
Tumori, Milano, IT
Jörg Pelz MD, University of Wuerzburg, Wuerzburg, DE
Pompiliu Piso MD, St. John of God Hospital, Regensburg, DE
Paolo Proto, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, IT
Horst-Geunter Rau, Amperklinikum, Dachau, DE
Pascal Rousset MD, Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon, FR
Paul H. Sugarbaker MD, Washington Cancer Center, Washington, US
Peter Thuss-Patience MD, Charité Campus Virchow-Klinikum, Berlin, DE
Kurt Van der Speeten MD, Ziekenhuis Oost-Limburg, Genk, BE
Florent Wallet MD, Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon, FR
Victor J. Verwaal MD, The Netherlands Cancer Institute, Amsterdam, NL
Aim of the Advanced Course
The ESSO Advanced Course “Management of HIPEC after CRS”
aims to discuss evidence-based clinical decision-making in the
management of primary and secondary peritoneal cancer and
will offer a multidisciplinary programme combining both practical
aspects and theoretical problems.
Technical and clinical approaches will be revisited and updated.
Presentations will include the state of the art and latest
advancements, videos with tips and tricks by the experts in the
field, and case reports.
Participants will perform cytoreductive surgery in small groups in
the wet lab using several new technical devices with supervision by
the experts. Therefore the workshop is limited to a small number of
participants (first come – first serve).
Ideal Advanced Course Candidate
• Senior residents (last two years of training)
• Experienced consultant surgeons
• Good in English, written and spoken
Educational Methods
•
•
•
•
•
•
•
Interdisciplinary approach
Plenary lectures
Workshops
Video discussions
Case reports
Hands on: several operations procedures in the operating room
Textbook and Video Atlas edited by Paul Sugarbaker offered
by FARGO (Foundation for Applied Research in Gastrointestinal
Oncology)
Partnerships
ESSO acknowledges the collaboration of the European Surgical
Institute (ESI) and the Berufsverband der Deutschen Chirurgen
(BDC).
Course Venue
European Surgical Institute
Hummelsbütteler Steindamm 71
D - 22851 Norderstedt
Tel. +49 (0)40-52 97 32 15
Website: www.esi-online.de
Course Accommodation
Steigenberger Hotel Treudelberg Hamburg
Lemsahler Landstraße 45
D-22397 Hamburg
Tel. +49 40 608 22 0
Fax +49 40 608 22 8888
Website: www.treudelberg.com
Course coordination
Ana Galán
European Society of Surgical Oncology (ESSO)
Email. [email protected]
Application Procedure
Application must include:
• Complete Application Form, available at www.essoweb.org
(education/projects & courses)
• Short CV (maximum 2 pages)
• Applications must be sent by e-mail to [email protected]
Participation fee
The participation fee is 800 EUR for members and 950 EUR for
non-members. It includes the registration to the 2-day course,
2-nights accommodation, coffee breaks and lunches and a social
dinner.
Accreditation
An application for accreditation has been submitted to the European
Accreditation Council for CME (EACCME) of the European Union
of Medical Specialists (UEMS).
Programme
Thursday 19 March
14:00-14:50
Introduction
Beate Rau
14:50-16:50
Treatment principles for peritoneal surface malignancies:
surgical approach and clinical-pathological pathway
Chairs Beate Rau - Marcello Deraco
14:50-15:20
Techniques of cytoreductive surgery with peritonectomy
procedures (CRS)
Paul Sugarbaker
15:20-15:35
Pharmacology of different techniques of Intraperitoneal
drug administration; role of heat and carriers
Kurt van de Speeken
15:35-15:50
HIPEC: different techniques and role of intra abdominal
pressure
Shigeki Kusamura
15:50-16:05
Clinical diagnostic pathway for PSM
Dario Baratti
16:05-16:20
Pathological diagnostic pathway for PSM
Massimo Milione
16:20-17:00
Coffee Break
17:00-18:45
Perioperative Management
Chairs 17:00-17:15
17:15-17:30
17:30-17:45
Paul Sugarbaker - Tom Cecil
OR personnel safety related to HIPEC
Jörg Pelz
Preoperative staging in peritoneal metastases: necessary
and nice to have (morphologic exams and peritoneal
carcinomatosis)
Pascal Rousset
To speak the same language: PCI, CCR and PSS
Gabriel Glockzin
17:45-18:00
Perioperative management of CRS and HIPEC:
view of anaesthesiologist
Paolo Proto
18:00-18:15
Prevention and management of postoperative general
complications
Florent Wallet
18:15-18:30
Prevention and management of postoperative surgical
complications related to CRS and HIPEC
18:30-18:45
Maik Kilian
How to start a new center for the treatment of PSM
Shigeki Kusamura
Friday 20 March
08:30-17:30
Operation room: hands on
Tutors
Dario Baratti, Tom Cecil, Marcello Deraco, Olivier Glehen,
Gabriel Glockzin, Santiago González-Moreno, Jens Hartmann, Christhardt Köhler, Maik Kilian, Shigeki Kusamura,
Jörg Pelz, Pompiliu Piso, Beate Rau, Horst-Geunter Rau,
Paul Sugarbaker, Kurt Van Der Speeten, Vic Verwaal
08:30-08:40
Preparation for the hands on: anatomical structure in animal
08:40-08:50
Ludwig K. Groebler
Debreefing from human to animal
Beate Rau
Right upper abdomen
• Right abdominal wall
08:40-11:05
• Interenteric
• Right diaphram arcus tendineum
• Resection gastric surface
• Bursa omentalis
• Splenectomy
• Pancreatic tail resection
11:05-11:25
Coffee Break
Left upper abdomen
• Left abdominal wall
11:25-12:30
• Left diaphram arcus tendineum
• Resection of serosal surface of bowel mesenterium
• Hepatoduodenal ligament
• Cholecystectomy
• Resection of small bowel
• Triangle ligament
• Morrison pouch
12:30-13:30
Lunch
Pelvic
• Resection of omentum
13:30-14:30
• Resection of serosal surface of bowel
• Resection of peritoneal surface of the bladder
• Lymph node preparation central mesenterical route
14:30-15:00
Coffee Break
15:00-15:30
Devices HIPEC open and devices HIPEC close
16:00-17:30
Discussion with the experts1
Saturday 21 March 2015
08:30-10:40
Frequent indications and systemic treatment
Chairs
Pompiliu Piso - Santiago González-Moreno
08:30-08:50
Pseudomyxoma peritonei (particularities of CRS, HIPEC and CCR score)
08:50-09:10
09:10-09:30
09:30-09:50
09:50-10:10
Tom Cecil
Malignant peritoneal mesothelioma and primay peritoneal carcinoma (particularities of CRS, HIPEC and CCR score)
Marcello Deraco
Peritoneal metastases from ovarian cancer
(particularities of CRS, HIPEC and CCR score)
Christhardt Köhler
Peritoneal metastases from gastric cancer (particularities of CRS, HIPEC and CCR score)
Santiago González-Moreno
Peritoneal metastases from colorectal cancer (particularities of CRS, HIPEC and CCR score)
Vic Verwaal
10.10-10.30
Treatment options in peritoneal metastases from
gastrointestinal origin: the medical oncology point of view
Peter Thuss-Patience
10.30-10.40
Ongoing clinical trials on G.I. cancer
Olivier Glehen
10:40-11:10
Coffee Break
11:10-13:00
Selection is the key ! Case reports (Videos)
Chairs Christhardt Köhler - Marcello Deraco
11:10-11:30
Selection criteria for CRS and HIPEC
11:30-11:45
11:45-12:00
12:00-12:15
12:15-12:30
12:30-13:00
Pompiliu Piso
Case 1 (PCI, SCORE, strategy, prognosis)
Colorectal Cancer Vic Verwaal
Case 2 (PCI, SCORE, strategy, prognosis)
Ovarian Cancer Christhardt Köhler
Case 3 (PCI, SCORE, strategy, prognosis)
Mesothelioma Dario Baratti
Case 4 (PCI, SCORE, strategy, prognosis)
Gastric Cancer Jens Hartmann
Conclusions and end of the course
ESSO is grateful for the continuous support of
its corporate sponsors
The advanced course is supported by:
pantone vollton coated 1805
European Society of Surgical Oncology (ESSO)
Avenue E. Mounier 83
B 1200 Brussels
Tel: +32 (0)2 5373106
Fax : +32 (0) 5390374
Email : [email protected]
Website : www.essoweb.org